AdvisorShares Pure US Cannabis ETF (MSOS)
| Assets | $559.38M |
| Expense Ratio | 0.83% |
| PE Ratio | 12.20 |
| Shares Out | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +0.43% |
| Volume | 3,549,451 |
| Open | 6.97 |
| Previous Close | 6.99 |
| Day's Range | 6.77 - 7.04 |
| 52-Week Low | 4.78 |
| 52-Week High | 9.88 |
| Beta | n/a |
| Holdings | 86 |
| Inception Date | Sep 1, 2020 |
About MSOS
Fund Home PageThe AdvisorShares Pure US Cannabis ETF (MSOS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed narrow portfolio of US stocks or swap contracts related to the domestic cannabis and hemp industry. MSOS was launched on Sep 1, 2020 and is issued by AdvisorShares.
Top 10 Holdings
171.09% of assets| Name | Symbol | Weight |
|---|---|---|
| Derivatives Collateral Nomura | n/a | 67.14% |
| Green Thumb Industries Swap | n/a | 27.23% |
| Curaleaf Holdings Inc Swap | n/a | 18.78% |
| Blackrock Treasury Trust Instl 62 | n/a | 14.88% |
| Verano Holdings Corp Swap | n/a | 12.17% |
| Trulieve Cannabis Swap | n/a | 10.33% |
| Derivatives Collateral Clearstreet | n/a | 8.43% |
| Cresco Labs Inc Swap | n/a | 5.12% |
| TerrAscend Corp | TSND.TO | 4.65% |
| Curaleaf Holdings Inc Swap | n/a | 2.35% |
News
Tax-loss selling makes these stocks in cannabis, pharma, energy and industrials worth buying
In an annual year-end ritual, investors have dumped many of their stock losers to offset taxable gains. This so-called “tax loss selling” can create buying opportunities in promising names.
These ETF strategies were big winners in 2023. Here's where one CFRA analyst sees them going next year.
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at ETF strategies that have exploded in popularity in 2023, and whether they will con...
Disruptive Tech Theme of the Week: Top Thematic ETF Flows 2023
To close out the year, I thought it would be interesting to see which thematic categories experienced the most inflows in 2023, demonstrating proverbially “where the puck was going.” This data, source...
2024's Cannabis Investment Landscape: Top Marijuana ETFs to Consider
The cannabis industry is rapidly evolving, attracting attention from investors seeking long-term growth. As legalization spreads globally, marijuana stocks and ETFs (Exchange-Traded Funds) are becomin...
ETF investors flee cash-like government bond funds, favor riskier assets in ‘bullish buying'
Hello! In this week's ETF Wrap, you'll get a look at flow data showing recent “bullish buying behavior” from investors, as well as funds to consider before 2024 hits.
Watchlist Alert: Best Cannabis ETFs for the Final Quarter of 2023
The cannabis sector continues to entice investors with its prospects for expansion and financial success as we take on the last quarter of 2023. Cannabis Exchange-Traded Funds (ETFs) have become popul...
Cannabis stock gains fade in volatile trading on US Senate bill hopes
Shares of marijuana companies gave back early gains on Wednesday after jumping following a U.S. Senate committee voted to advance a bill that would give legal cannabis-related companies a boost by all...
A key Marijuana financing bill moves forward in the U.S. Senate
Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co...
Cannabis stock rise as Senate committee OKs cannabis banking bill
Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking...
Cronos stock climbs after launching Peace Naturals medical cannabis brand in Germany
The U.S.-listed shares of Cronos Group Inc. CRON, -3.24% CRON, -3.56% climbed 2.5% in premarket trading Monday, after the Toronto-based cannabis company said it launched its Peace Naturals medical bra...
Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27
The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.
Marijuana Watchlist: September 2023's Standout ETFs in Cannabis
In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory lan...
Cannabis banking measure may win approval in Senate, report says
The Secure and Fair Enforcement (SAFE) Act, also known as the SAFE Banking Act, will be voted on in committee by the end of the month and should have enough votes to pass the U.S. Senate, according to...
Cannabis ETFs boom as HHS recommendation to ease restrictions raises hopes for federal reform
Marijuana-related ETF's are trading higher in September after HHS recommended that the U.S. reclassify and ease restrictions on marijuana.
Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cann...
This Cannabis ETF Is Up 66% In 5 Days, Options Traders Bet It's Going Even Higher - AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (ARCA:MSOS)
AdvisorShares Pure US Cannabis ETF MSOS rose sharply on Tuesday, extending gains from the previous week.
Options Action: Traders bet big on cannabis stocks
Mike Khouw, Optimize Advisors president, joins CNBC's Melissa Lee and the Options Action traders to talk pot stocks.
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q...
Pot firms gain as US move to ease curbs boosts sentiment
Shares of marijuana companies climbed as much as 14% in morning trading on Thursday after the Department of Health and Human Services recommended its reclassification as a lower-risk substance followi...
Options Action: Options trader bets cannabis ETF hits $10 by January
Mike Khouw, Optimize Advisors president, joins CNBC's Melissa Lee and the Options Action traders to talk a bullish bet in the cannabis space.
Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category
The Drug Enforcement Agency received an official recommendation to downgrade marijuana. Currently, pot is classified as a Schedule I drug, on par with heroin.
U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally
The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law ...